CIK 0001680581
- Non-accelerated filer
- Smaller reporting company
Fulcrum Therapeutics, Inc.
Sign in to watch- Ticker
- FULC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 474839948
- Phone
- +1 617-651-8851
- Business address
- 26 LANDSDOWNE STREET, CAMBRIDGE, MA, 02139
- 4 Open-market buy Chief Medical Officer bought 1,100 shares at $9.16 ($10,076)
- 4 Open-market buy SVP, General Counsel bought 1,088 shares at $9.01 ($9,803)
- 4 Open-market buy VP Finance & Accounting bought 2,300 shares at $9.00 ($20,700)
- 4 Open-market buy Director bought 10,000 shares at $9.16 ($91,600)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale See Remarks sold 10,000 shares at an average $12.16 ($121,578)
- 4 Open-market sale VP Finance & Accounting sold 5,000 shares at $14.72 ($73,582)
- 4 Open-market sale See Remarks sold 8,215 shares at an average $14.27 ($117,197)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
Page 7 of 12 · 221 filings